H-Index
70
Scimago Lab
powered by Scopus
Clarivate
Analytics
Formerly the IP & Science
business of Thomson Reuters

Logo




eISSN: 1643-3750

Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.

Daad H. Akbar, Abeer H. Kawther

Med Sci Monit 2006; 12(1): RA23-26

ID: 443211

Published: 2005-12-22


NAFLD is a very common asymptomatic liver condition that may progress tocirrhosis and hepatocellular carcinoma, and a relation to the different components of the metabolic syndromehas been found. In this review we highlight some of the epidemiological aspects of the two disordersand discuss some of the possible mechanisms and questions to be answered concerning the risk factorsfor the progression of this condition as well as the need for more studies to focus on possible modalitiesof treatment.

Keywords: Fatty Liver - physiopathology, Diabetes Mellitus, Type 2 - physiopathology, Humans, Metabolic Syndrome X - physiopathology, Prognosis, Risk Factors



Back